Stretch mark removal treatments that actually work

Stretch marks are common dermal scars. They can appear after pregnancy, puberty, rapid body-size change, muscle growth or certain hormonal and medication-related changes. They often fade with time, but a mature stretch mark is not something a cream or device can simply erase.

That distinction matters because “stretch mark removal” is a much stronger claim than “improving the appearance of stretch marks”. Current evidence supports several treatments that may reduce width, colour contrast or textural irregularity in selected patients, but no single method reliably removes every stretch mark.

The stage of the striae, skin type, location, previous treatment and tolerance for recovery all affect planning. Red or purple marks are biologically different from older white or silvery marks, and a treatment that targets colour is not automatically the same as one designed to remodel texture.

The medical term for stretch marks is striae distensae. They are linear, atrophic changes within the dermis rather than a superficial stain sitting on top of otherwise normal skin.

Rapid mechanical change is part of the story, but stretch marks are not caused by stretching alone. Hormonal influences, genetics, corticosteroid exposure and changes in the dermal extracellular matrix also contribute.

This explains why two people can go through similar weight change or pregnancy and develop very different degrees of striae. It also explains why treatment outcomes vary: the target is altered dermal tissue, not simply colour on the skin surface.

Early stretch marks are often called striae rubrae. They may look red, pink or violaceous because vascular and inflammatory features are more prominent. With time, many become striae albae — paler, more atrophic and often silvery-white.

This stage difference affects treatment logic. Reviews generally find that earlier red striae can respond more favourably than older white striae, while mature striae often require approaches focused on dermal remodelling rather than colour alone.

The transition is gradual, not a switch that happens on a fixed date. A consultation should assess the actual appearance rather than assuming age from how long the patient remembers the marks being present.

No treatment can be promised to remove stretch marks completely.

The more defensible language is that selected treatments may improve the appearance, width, texture or colour contrast of striae in some patients. The amount of improvement varies.

This is not just cautious wording. A 2024 systematic review found a very wide range of treatment approaches and relatively low rates of complete response, illustrating how difficult striae are to eliminate.

Stretch marks commonly develop during pregnancy, puberty, rapid weight gain or loss and periods of rapid muscle growth. They can also be associated with corticosteroid use and endocrine conditions such as Cushing’s syndrome.

Most striae are benign and need no medical treatment. However, sudden extensive striae without an obvious explanation, new marks in the context of prolonged steroid use, or striae accompanied by other systemic symptoms are reasons to consider medical assessment rather than treating them as a purely cosmetic issue.

Aesthetic treatment should not obscure a possible underlying cause.

Moisturisers can make skin feel softer and more comfortable, but that is different from preventing or removing stretch marks. NHS guidance notes that there is limited evidence that oils or creams prevent pregnancy-related stretch marks, and CAP states that it has not seen sufficient evidence that moisturisers remove established striae.

Specific topical products may have individual evidence, but a general claim that cocoa butter, oils or moisturising creams prevent stretch marks is not well supported.

If the aim is prevention during pregnancy or body-size change, maintaining comfortable skin care is reasonable, but expectations should stay modest.

Morpheus8 combines microneedling with radiofrequency energy. Because needles enter the skin, it is more accurately described as minimally invasive, not non-invasive.

The current Dr Ducu Clinics stretch-mark page lists Morpheus8 as a treatment option and states that it may improve the appearance and texture of stretch marks, with outcomes varying between individuals.

The broader evidence base supports this cautious wording. A 2024 systematic review and meta-analysis found evidence of clinical improvement with microneedling-based treatments, including fractional microneedle radiofrequency, while also highlighting variation in study design and treatment protocols.

A separate 2024 meta-analysis comparing fractional microneedle radiofrequency with fractional CO2 laser found similar overall improvement between the two approaches, with a lower rate of post-inflammatory hyperpigmentation in the radiofrequency-microneedling group.

That does not make Morpheus8 appropriate for everyone. Settings, skin type, striae stage, treatment area and healing history all matter.

Conventional microneedling and radiofrequency microneedling should not be treated as identical procedures. Both create controlled micro-injury, but radiofrequency microneedling also delivers thermal energy at depth.

Meta-analytic evidence suggests that microneedling can improve striae and may perform comparably to some laser approaches in selected studies. The evidence is encouraging, but protocols vary in needle depth, number of passes, treatment interval and outcome scoring.

That heterogeneity is exactly why a fixed promise such as “three sessions will remove stretch marks” is not defensible.

Fractional lasers are among the better-studied procedural categories for striae. Both ablative and non-ablative fractional systems have been investigated.

A 2025 meta-analysis comparing fractional CO2 laser with microneedling found broadly comparable clinical improvement, while post-inflammatory hyperpigmentation occurred more frequently in the CO2-laser groups.

A 2024 network meta-analysis of energy-based devices did not identify one universally superior technology for reduction in striae width. Radiofrequency, ablative lasers, non-ablative lasers and intense pulsed light all showed activity in the included trials.

The main practical point is that “laser” is not one treatment. Wavelength, pulse duration, fluence, fractional density, skin type and the age of the striae all affect both potential benefit and risk.

Picosecond lasers have emerging evidence for striae. Small clinical studies have reported improvement in texture and depth, including studies involving mature white stretch marks and darker Fitzpatrick skin types.

Intense pulsed light has also been studied, particularly for colour-related features of striae rubrae. The evidence is older and more heterogeneous, so it should not be assumed that every IPL or broadband-light protocol has the same effect.

This is relevant to the current Dr Ducu Clinics service structure. The clinic currently offers PicoSure and BBL for other stated indications, but the dedicated stretch-mark treatment page specifically lists Morpheus8 as the stretch-mark option. PicoSure or BBL should therefore not be presented as standard Dr Ducu stretch-mark treatments unless the clinic’s treatment pathway changes and the relevant evidence is documented.

Device names alone are not evidence. The exact device, wavelength, handpiece and protocol need to match the claim being made.

Topical tretinoin has published evidence for improving the appearance of some early, active stretch marks, particularly at higher studied concentrations. Other trials using lower concentrations have not shown the same benefit.

This mixed evidence matters, but there is an additional UK issue: tretinoin is a prescription-only medicine. Public-facing clinic content should not promote it directly to consumers as a stretch-mark treatment.

Where a prescription topical retinoid may be clinically relevant, that belongs in an appropriate consultation rather than a consumer “best treatment” list. Pregnancy status and other contraindications also need medical consideration.

Post-inflammatory hyperpigmentation is an important consideration after procedures that create heat or controlled injury. The risk varies with device, settings, recent tanning, inflammation history and Fitzpatrick skin type.

In comparative evidence, fractional CO2 laser has shown a higher PIH rate than fractional microneedle radiofrequency in some analyses. That does not mean one modality is always safer for every darker skin type, but it reinforces the need for conservative settings and treatment-specific expertise.

Skin colour should not be used as a shortcut to suitability. The clinician should consider baseline pigmentation, history of PIH, active tan, keloid or hypertrophic-scar tendency and the exact device being proposed.

There is no evidence-based session number that applies to every stretch mark and every device. Suggestions such as three to five sessions at four- to six-week intervals can be a starting point, but the plan should be adjusted to the individual.

The current Dr Ducu Clinics stretch-mark page now takes the more appropriate position: the number of sessions depends on the treatment, area, appearance of the striae and individual response.

Published studies use very different treatment schedules. That is one reason results from one protocol should not be copied onto another device.

A sensible treatment course should include planned reassessment rather than automatically committing every patient to the same package.

Recovery depends on the modality. Microneedling and radiofrequency microneedling can cause redness, swelling, tenderness and temporary pinpoint crusting. Laser treatment can also cause erythema, swelling, crusting and pigment change, with recovery depending on whether the device is ablative or non-ablative and on the treatment intensity.

Sun exposure after treatment can increase the risk of pigmentary change, so aftercare commonly includes photoprotection and gentle skin care. The exact instructions should match the procedure performed.

“No downtime” is not an appropriate blanket promise. A patient may be medically able to resume normal activity while still having visible redness, swelling or texture change.

A careful consultation should first confirm that the lines are typical stretch marks and not another dermatological problem. The clinician should ask when they appeared, whether they are still changing, whether corticosteroids are being used and whether there are relevant medical or hormonal symptoms.

For treatment planning, the important variables are stage, colour, depth, location, skin type, tanning history, prior treatments and tolerance for recovery.

The consultation should also define what success means. For one patient, the priority may be reducing colour contrast; for another, improving texture or width. A treatment plan is more useful when it targets one defined feature than when it promises generic “removal”.

Stretch marks are difficult to treat because they are not one simple surface problem. Colour, dermal atrophy, collagen architecture and skin type all influence what is visible.

The current evidence supports several modalities that may improve appearance, including microneedling, radiofrequency microneedling and selected laser or light-based treatments. It does not support promising complete removal, a fixed number of sessions or one universally superior technology.

A useful plan therefore begins with the stage of the striae and the feature that matters most, then balances potential improvement against recovery, pigmentary risk and the quality of evidence for the exact treatment being considered.

Related treatment: Stretch marks